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Interferon (IFN)-inducible guanylate binding proteins (GBPs) mediate cell-autonomous host resistance to bacterial pathogens
and promote inflammasome activation. The prevailing model postulates that these two GBP-controlled activities are directly
linked through GBP-dependent vacuolar lysis. It was proposed that the rupture of pathogen-containing vacuoles (PVs) by GBPs
destroyed the microbial refuge and simultaneously contaminated the host cell cytosol with microbial activators of inflam-
masomes. Here, we demonstrate that GBP-mediated host resistance and GBP-mediated inflammatory responses can be uncou-
pled. We show that PVs formed by the rodent pathogen Chlamydia muridarum, so-called inclusions, remain free of GBPs and
that C. muridarum is impervious to GBP-mediated restrictions on bacterial growth. Although GBPs neither bind to C. muri-
darum inclusions nor restrict C. muridarum growth, we find that GBPs promote inflammasome activation in C. muridarum-
infected macrophages. We demonstrate that C. muridarum infections induce GBP-dependent pyroptosis through both caspase-
11-dependent noncanonical and caspase-1-dependent canonical inflammasomes. Among canonical inflammasomes, we find that
C. muridarum and the human pathogen Chlamydia trachomatis activate not only NLRP3 but also AIM2. Our data show that
GBPs support fast-kinetics processing and secretion of interleukin-1 (IL-1) and IL-18 by the NLRP3 inflammasome but are
dispensable for the secretion of the same cytokines at later times postinfection. Because IFN- fails to induce IL-1 transcrip-
tion, GBP-dependent fast-kinetics inflammasome activation can drive the preferential processing of constitutively expressed
IL-18 in IFN--primed macrophages in the absence of prior Toll-like receptor stimulation. Together, our results reveal that
GBPs control the kinetics of inflammasome activation and thereby shape macrophage responses to Chlamydia infections.
Gram-negative bacterial species of the genus Chlamydia areobligate intracellular pathogens that replicate within the con-
fines of a vacuole referred to as an inclusion. Chlamydia species
have narrow host ranges and cause a variety of diseases in their
respective animal and human hosts (1). Two Chlamydia species,
Chlamydia pneumoniae and Chlamydia trachomatis, are human-
adapted pathogens. C. pneumoniae infects alveolar epithelial cells
and macrophages, causing acute respiratory as well as chronic
diseases (2). C. trachomatis predominantly invades epithelial cells
and is responsible for various disease manifestations that depend
on the specific bacterial strain and the site of the infection: ocular
C. trachomatis strains infect conjunctival epithelial cells, resulting
in trichiasis, corneal opacification, and blindness; genital C. tra-
chomatis strains infect cervical epithelial cells and can cause pelvic
inflammatory disease and infertility (3). The estimated number
of new cases of sexually transmitted C. trachomatis infections
amounts to 100 million worldwide per annum, signifying the
prevalence of this routinely underreported infection (4).
Because acute C. trachomatis infections in women are com-
monly asymptomatic or cause only mild or nonspecific symp-
toms, infections often go unnoticed and untreated. A substantial
proportion of these untreated infections can progress toward
chronic infections that are associated with numerous complica-
tions, including chronic pelvic pain, salpingo-oophoritis, fibrosis,
and tubal occlusion (3). Host inflammation is believed to be the
dominant culprit of these underlying sequelae. This hypothesis is
well supported by numerous studies conducted in mouse models
(3). In murine infection models the rodent-adapted species Chla-
mydia muridarum is often used as the infectious agent instead of
C. trachomatis. C. muridarum was first isolated from the lungs of
albino Swiss mice that showed flu-like symptoms (5). When in-
stilled into mouse lungs, C. muridarum replicates inside alveolar
macrophages and causes pneumonia, suggesting that C. muri-
darum is primarily a pulmonary pathogen (6, 7). Subsequently, it
was shown that C. muridarum could be used to establish genital
tract infections that typically resolve within 2 months yet result in
oviduct pathologies (8, 9). The incidence and severity of these
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pathologies is diminished in mice concomitantly deficient for two
proinflammatory caspases, caspase-1 and caspase-11 (10), sug-
gesting a role for the inflammasome in Chlamydia-induced pa-
thologies. Additionally, mice deficient in ASC, a central compo-
nent of many inflammasomes, develop increased infectious
burden and show a delay in the clearance of genital C. muridarum
infections (11), suggesting a role for inflammasomes in host resis-
tance to Chlamydia infections in vivo.
Inflammasome complexes typically consist of an upstream
sensor protein, the downstream effector proteases caspase-1,
caspase-11 (CASP4/5 in humans) or caspase-8, and an adaptor
protein, for instance, ASC (12). Inflammasome assembly and activa-
tion occur in response to pathogen-associated molecular patterns
(PAMPs) and damage-associated molecular patterns (DAMPs). The
majority of sensor proteins, including NLRP3 and AIM2, assemble
with caspase-1 to form canonical inflammasomes. Once assembled,
canonical inflammasomes can process the cytokines interleukin-1
(IL-1) and IL-18 and execute pyroptosis, a type of proinflammatory
cell death (12). The proinflammatory caspase-11, on the other hand,
is unique in its dual role as both sensor and effector protein of the
noncanonical inflammasome. Caspase-11 was shown to bind to lipo-
polysaccharide (LPS), induce pyroptosis, and activate the NLRP3 in-
flammasome (13–16). Whereas the importance of caspase-11 in
Chlamydia pathogenesis was not previously examined, earlier
studies showed that Chlamydia infections activate the NLRP3 in-
flammasome (17, 18). Potassium efflux from the cytosol, lyso-
somal acidification, and cathepsin B release from damaged lyso-
somes were identified as Chlamydia infection-associated patterns
that contribute to NLRP3 activation (18). While the aforemen-
tioned studies focused on Chlamydia-induced responses in
unprimed host cells, subsequent studies using LPS-primed mac-
rophages revealed that infections with Chlamydia activate inflam-
masomes other than NLRP3, although the identity of these addi-
tional Chlamydia-activated inflammasomes was not reported
(11).
Macrophage priming augments infection-induced inflam-
masome responses (12). One class of proteins induced by LPS and
other stimuli such as gamma interferon (IFN-) are members of
the GBP family of IFN-inducible GTPases (19). Recently, it was
shown that GBPs promote the lysis of Salmonella-containing vac-
uoles and stimulate caspase-11 activation (20). Because caspase-11
guards cells against Gram-negative bacteria entering the cytosol
(21), the execution of pathogen-containing vacuole (PV) lysis was
proposed to be the underlying function for GBPs in caspase-11
activation (20). However, our studies on inflammasome activa-
tion by Legionella pneumophila indicated a role for GBPs in
caspase-11 activation that was independent of PV lysis (22). In the
current study, we examined the role of GBPs in orchestrating in-
flammasome-dependent cellular responses to Chlamydia infec-
tions. We demonstrate that C. muridarum inclusions are imper-
vious to GBP binding; therefore, they are resistant to GBP-driven
host responses that result in the immediate destruction of the
microbe and its vacuolar niche. Although GBP protein family
members GBP2 and GBP1 fail to localize to C. muridarum inclu-
sions, we show that GBPs promote the induction of pyroptosis
through both noncanonical and canonical inflammasomes. We
further demonstrate that GBPs promote fast-kinetics but not
slow-kinetics inflammasome activation in response to C. muri-
darum infections. Because IFN- priming fails to induce IL-1
expression, the induction of GBP expression by IFN- favors the
rapid processing of constitutively expressed IL-18 by NLRP3.
These data reveal a unique role for GBPs as accelerators of inflam-
masome activation in response to Chlamydia infections and fur-
ther show that the kinetics of inflammasome activation can regu-
late the relative secretion of IL-18 versus IL-1, two cytokines with
distinct biological activities.
MATERIALS AND METHODS
Cell culture, bacterial strains, infection procedures, and evaluation of
bacterial burden. Murine embryonic fibroblasts (MEFs) and Vero cells
were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with nonessential amino acids, 2-mercaptoethanol, and 10%
heat-inactivated fetal bovine serum (FBS). To ectopically express GFP-
GBP1 fusion protein (where GFP is green fluorescent protein), MEFs were
transduced with a previously described retroviral expression vector (23).
Macrophages were derived from bone marrow isolated from the indicated
mouse lines. Wild-type C57/BL6J mice were purchased from Jackson Lab-
oratories. GBPchr3/ mice harbor a deletion of a cluster of 5 Gbp genes
located on mouse chromosome 3 and were previously described (24).
Nlrp1/, Nlrp3/, Nlrc4/, Aim2/, Nlrp3/ Aim2/, Asc/,
Casp1/, Casp11/, and Casp1/ Casp11/ mice were previously
described (25–33). BMMs were cultured in RPMI 1640 supplemented
with 2-mercaptoethanol, 20% FBS, and 14% conditioned media contain-
ing macrophage colony-stimulating factor. C. muridarum Nigg and C.
trachomatis serovar L2 434/Bu were propagated in Vero cells and purified
as previously described (34). A previously described GFP expression vec-
tor (35) was introduced into LGV-L2 for visualizing C. trachomatis. C.
trachomatis and C. muridarum elementary bodies (EBs) were purified by
sequential density gradients, as described previously (36). The multiplic-
ity of infection (MOI) for all experiments was defined based on the infec-
tivity of the purified EB stocks in unprimed Vero cells. For infections, C.
muridarum or C. trachomatis was diluted in appropriate culture medium
and added to plates at the indicated MOI. To assess bacterial replication in
macrophages, BMMs were infected at the relatively low MOI of 3 to min-
imize MOI-dependent restriction of bacterial growth, as recently reported
(37). To monitor the activation of pyroptosis, BMMs were infected at the
relatively high MOI of 30. Plates then were centrifuged for 30 min at
1,560  g at 10°C in a Sorvall ST 40R centrifuge (Thermo Scientific). The
bacterial burden in infected BMMs was determined via quantitative PCR
(qPCR) as previously described (38).
Immunocytochemistry and data analysis. Cells were washed with
phosphate-buffered saline (PBS), pH 7.4, prior to fixation. Cells were
fixed with methanol for 5 min, washed thrice with PBS, and blocked in 5%
bovine serum albumin for 30 min at room temperature. C. muridarum
and C. trachomatis inclusions were stained with a mouse monoclonal
antibody against Chlamydia LPS (used at 1:50; Santa Cruz Biotechnol-
ogy). A previously described rabbit polyclonal anti-GBP2 antibody (39)
was used at 1:1,000. Following incubation with primary antibodies, cells
were stained with Alexa Fluor-conjugated secondary antibodies (Molec-
ular Probes) and Hoechst. For colocalization studies, MEFs were infected
with C. muridarum or C. trachomatis at an MOI of 1 and fixed for 24 h
postinfection (hpi). The fraction of GBP2-positive inclusions was deter-
mined by dividing the number of GBP2-positive inclusions by the total
number of counted inclusions. For macrophage studies, cells were in-
fected with C. muridarum at an MOI of 3 and fixed 24 hpi. The percentage
of inclusion-positive BMMs was determined by dividing the number of
BMMs containing an inclusion by the total number of counted macro-
phages and multiplied by 100. Imaging was performed using a Zeiss Ax-
ioskop 2 upright epifluorescence microscope, a Zeiss LSM 510 inverted
confocal microscope, or a Leica SP5 inverted confocal microscope.
Cytotoxicity assay and data analysis. BMMs were seeded at a density
of 4.0  105 cells per well into 96-well plates. BMMs were primed with
IFN- (100 U/ml) or LPS (100 ng/ml) or were left unprimed for 16 h.
Following priming, BMMs were infected with C. muridarum or C. tracho-
matis at an MOI of 30. Cytotoxicity was measured 8 hpi as a function of
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relative lactate dehydrogenase (LDH) release using the CytoTox One ho-
mogeneous membrane integrity assay (Promega). Relative LDH release
was calculated with the following formula: (LDH sample – LDH untreated
control)/(LDH lysed control – LDH untreated control)  100. Measure-
ments were performed on an EnSpire 2300 (PerkinElmer) multilabel
reader.
Cytokine measurements. BMMs were seeded at a density of 4.0  105
cells per well into 96-well plates. BMMs were primed with IFN- (100
U/ml) or LPS (100 ng/ml) or were left unprimed for 6 h. Following prim-
ing, BMMs were infected with C. muridarum or C. trachomatis at an MOI
of 30. Supernatants were collected 8 and 24 hpi and stored at 80°C until
analysis. IL-1 and Il-18 were measured by enzyme-linked immunosor-
bent assay (ELISA; BioLegend/eBioscience). Measurements were per-
formed on an EnSpire 2300 (PerkinElmer) multilabel reader.
Quantitating mRNA levels. BMMs were primed with IFN- (100
U/ml) or LPS (100 ng/ml) or were left unprimed for 16 h. Where indi-
cated, BMMs then were infected with C. muridarum at an MOI of 30 or 3.
RNA from BMMs was isolated following priming or 4 and 8 h postinfec-
tion using the RNeasy minikit (Qiagen) by following the manufacturer’s
instructions. RNA was reverse transcribed using the iScript cDNA synthe-
sis kit (Bio-Rad Laboratories), and qPCR was performed with PerfeCTa
SYBR green FastMix (Quanta BioSciences) using a StepOnePlus real-time
PCR system (Applied Biosystems). Relative mRNA levels were calculated
by normalization against transcript levels of glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). The following primers were used: mGBP2 F,
5=-CTGCACTATGTGACGGAGCTA-3=; mGBP2 R, 5=-GAGTCCACAC
AAAGGTTGGAAA-3=; mGBP3 F, 5=-GAGGCACCCATTTGTCTGGT-
3=; mGBP3 R, 5=-CCGTCCTGCAAGACGATTCA-3=; mGBP5 F, 5=-CAG
ACCTATTTGAACGCCAAAGA-3=; mGBP5 R, 5=-TGCCTTGATTCTA
TCAGCCTCT-3=; mGBP7 F, 5=-TCCTGTGTGCCTAGTGGAAAA-3=;
mGBP7 R, 5=-CAAGCGGTTCATCAAGTAGGAT-3=; mIL-1 F, 5=-GCA
ACTGTTCCTGAACTCAACT-3=; mIL-1 R, 5=-ATCTTTTGGGGTCC
GTCAACT-3=; mIL-18 F, 5=-GACTCTTGCGTCAACTTCAAGG-3=;
mIL-18 R, 5=-CAGGCTGTCTTTTGTCAACGA-3=; mGAPDH F, 5=-GG
TCCTCAGTGTAGCCCAAG-3=; mGAPDH R, 5=-AATGTGTCCGTCG
TGGATCT-3=.
Statistical analysis. Where designated, statistical significance was de-
termined using the unpaired Student t test or two-way analysis of variance
(ANOVA), as appropriate. The level of significance was depicted as P 
0.05 (*), P  0.01 (**), and P  0.001 (***).
RESULTS
Chlamydia muridarum is resistant to GBP-mediated cell-au-
tonomous immunity in macrophages. While IFN--induced
cell-autonomous immune responses efficiently restrict the growth
of the human-adapted pathogen C. trachomatis in murine cells,
the growth of the closely related rodent-adapted pathogen C. mu-
ridarum in murine cells is largely unchanged by IFN- priming (9,
40). In agreement with these previous observations, we found that
IFN- priming did not have a significant effect upon C. muri-
darum burden in bone marrow-derived macrophages (BMMs) as
assessed by qPCR (Fig. 1A). Likewise, we detected no significant
change in the number of inclusion-bearing BMMs at 24 h postin-
fection (hpi) with IFN- priming (Fig. 1B). Because we previously
observed that IFN--mediated restriction of C. trachomatis in
murine cells was dependent on a set of 5 GBPs (GBP1, GBP2,
GBP3, GBP5, and GBP7) encoded by mouse chromosome 3 (41),
we asked whether the same set of GBPs affected C. muridarum
burden in IFN--primed BMMs. We found that GBPchr3/
BMMs lacking all 5 GBP genes on chromosome 3 were as permis-
sive for C. muridarum growth as wild-type BMMs (Fig. 1A). These
data suggested that C. muridarum escaped from GBP-mediated
host defense pathways that directly intervene with bacterial repli-
cation or survival.
A second set of antimicrobial GTPases involved in cell-auton-
omous immunity to Chlamydia infections is the immunity-re-
FIG 1 C. muridarum resists GBP-mediated cell-autonomous immunity. (A)
Wild-type and GBPchr3/ BMMs were primed with 100 U/ml IFN- over-
night or left unprimed and subsequently infected with C. muridarum at an
MOI of 3. At 24 hpi, DNA was extracted from infected BMMs and bacterial
burden was determined via qPCR. Data are presented as means  SEM from 3
independent experiments. Statistical significance was calculated via two-way
ANOVA. N.S., not significant. (B) Following infection with C. muridarum,
wild-type BMMs were fixed at 24 hpi and stained with anti-LPS antibody and
Hoechst. The percentage of macrophages containing inclusions with multiple
bacteria (10) was quantified. Data are shown as means  SEM from 3 inde-
pendent experiments. Statistical significance was calculated using Student’s t
test. N.S., not significant. (C and D) IFN--primed MEFs were infected with C.
trachomatis or C. muridarum at an MOI of 1 and stained with Hoechst, anti-
Chlamydia LPS, and anti-GBP2 antibodies. (D) Frequency of GBP2 localiza-
tion to inclusions was quantified. (E) MEFs ectopically expressing GFP-GBP1
were primed with IFN- and infected with C. trachomatis or C. muridarum at
an MOI of 1. The frequency of GFP-GBP1 localization to inclusions was quan-
tified. Data shown for panels D and E represent means  SEM from 	800
inclusions and 2 independent experiments. N.D., none detected.
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lated GTPases (IRGs) (42–44). We previously showed that C. mu-
ridarum precludes these antimicrobial IRGs from docking to its
surrounding inclusion membrane and thereby evades IRG-medi-
ated immune responses (39). Because IRGs control the transloca-
tion of GBPs to PVs (45), we hypothesized that C. muridarum
could block not only IRGs but also GBPs from docking to its
inclusion. To test this idea, we infected IFN--primed cells with
either C. trachomatis or C. muridarum and monitored the subcel-
lular localization of GBP2 at 24 hpi. Since we failed to detect any C.
trachomatis inclusions in IFN--primed BMMs (data not shown),
we conducted these experiments in mouse embryonic fibroblasts
(MEFs). As previously reported (41, 45), we found that GBP2
decorated C. trachomatis inclusions efficiently (Fig. 1C and D). In
contrast to the robust targeting of endogenous GBP2 to C. tracho-
matis inclusions, we found that GBP2 was absent from C. muri-
darum inclusions formed either in MEFs (Fig. 1C and D) or in
macrophages at various times postinfection (data not shown; also
see Fig. S1 in the supplemental material). Similar to endogenous
GBP2, ectopically expressed GFP-GBP1 colocalized with C. tra-
chomatis but not C. muridarum inclusions (Fig. 1E). More detailed
studies on the mechanism of GBP binding to C. trachomatis inclu-
sion membranes confirmed these observations (46). Together,
these data indicated that C. muridarum barred GBPs from binding
to its surrounding inclusion membrane, an activity likely under-
lying the observed resistance of C. muridarum to GBP-mediated
bactericidal or bacteriostatic effects that help eliminate infections
with C. trachomatis.
GBPs promote pyroptosis in Chlamydia-infected, IFN--
primed macrophages. We and others previously demonstrated
that GBPs promote caspase-11-dependent pyroptosis in response
to infections with the Gram-negative bacterial species L. pneumo-
phila and Salmonella enterica serovar Typhimurium (20, 22).
While one study reported that GBPs disrupted PVs, enabling bac-
teria to enter the host cytosol and activate caspase-11 (20), our
data suggested that GBPs acted downstream of PV lysis (22). To
test these two models further, we monitored cell death in response
to infections with the aforementioned closely related Chlamydia
species C. trachomatis and C. muridarum, which fundamentally
differ in their permissiveness for GBP binding to their respective
inclusions (Fig. 1C to E). We used density gradient-purified Chla-
mydia (EBs) to infect BMMs and found that infections with either
GBP-permissive C. trachomatis (Fig. 2A) or GBP-resistant C. mu-
ridarum (Fig. 2B) triggered substantial GBP-dependent cell death
in IFN--primed BMMs at 8 hpi. The observed cell death was
dependent on inflammatory caspases 1 and 11, indicative of py-
roptosis (Fig. 2A and B). These results suggested a role for GBPs in
the rapid activation of inflammasomes that was independent of
GBP binding to PVs; therefore, it also was independent of GBP-
mediated PV lysis.
C. muridarum infection triggers GBP-dependent IL-18 se-
cretion in IFN--primed macrophages. Density gradient-puri-
fied C. muridarum EBs induced only moderate secretion of either
IL-18 or IL-1 in naive macrophages over the course of 24 hpi
(Fig. 3A and B and data not shown), which is in agreement with
the general characterization of Chlamydia as a stealth pathogen.
Since inflammasome activation in naive BMMs was poor, we next
asked whether macrophage priming would increase inflam-
masome-mediated cytokine secretion following C. muridarum in-
fections. We found that IFN- priming led to a 3-fold increase in
IL-18 and a 2-fold increase in IL-1 secretion in C. muridarum-
infected wild-type BMMs (Fig. 3A and B). These data suggested
that IFN- priming promoted inflammasome activation in re-
sponse to C. muridarum infections, possibly through the induc-
tion of core inflammasome components or the induction of addi-
tional auxiliary host proteins.
Because GBPs were required for the rapid induction of pyrop-
tosis in response to Chlamydia infections (Fig. 2A and B), we in-
vestigated their possible involvement in IL-1 or IL-18 secretion.
As expected, we observed that Casp1/ Casp11/ BMMs were
deficient for IL-18 or IL-1 secretion (Fig. 3A and B). We further
noticed that GBPs promoted IL-18 secretion but were unexpect-
edly dispensable for IL-1 secretion induced by C. muridarum
infections in IFN--primed BMMs at 24 hpi (Fig. 3A and B). To
account for this observation, we considered that GBPs controlled
either IL-1 or IL-18 mRNA expression based on the previous
characterization of GBPs as transcriptional regulators of cytokine
expression (47). Refuting this hypothesis, we found IL-18 tran-
script levels to be similar between wild-type and GBPchr3/
BMMs under both primed as well as unprimed conditions and in
the presence or absence of an infection (Fig. 3C; also see Fig. S2 in
the supplemental material). Although we observed a minor de-
crease in IL-1 mRNA levels in GBPchr3/ BMMs (Fig. 3D), the
biological relevance of this decrease seemed unclear, since IL-1
FIG 2 GBPs promote pyroptosis in Chlamydia-infected macrophages. Wild-
type, GBPchr3/, and Casp1/ Casp11/ BMMs were primed with 100
U/ml IFN- for 6 h or left unprimed. LDH release from C. trachomatis-in-
fected (Ct) (A) or C. muridarum-infected (Cm) (B) BMMs was measured at 8
hpi. Infections were carried out at an MOI of 30. Data are given as means 
standard deviations (SD) from 4 independent wells. Data are representative of
3 experiments. Statistical significance was calculated using two-way ANOVA
(*, P  0.05; ***, P  0.001).
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secretion was unchanged in GBPchr3/ BMMs (Fig. 3B). There-
fore, we pursued the alternative hypothesis that GBPs could reg-
ulate the kinetics of inflammasome activation and thereby skew
the macrophage response toward the preferential processing of
constitutively expressed pro-IL-18 available at early times postin-
fection (48).
GBPs promote fast-kinetics inflammasome activation in re-
sponse to C. muridarum infections. We hypothesized that GBPs
could promote inflammasome activation at early times postinfec-
tion when constitutively expressed pro-IL-18 but not pro-IL-1
was available for caspase-1-mediated processing in IFN--primed
BMMs. This hypothesis demanded that priming conditions that
simultaneously induced the expression of pro-IL-1 and GBPs
render IL-1 secretion GBP dependent at early times postinfec-
tion. One priming agent that induced robust IL-1 transcription
is LPS (Fig. 4A), as previously demonstrated (12). LPS priming
also induced the robust expression of GBP2, GBP3, GBP5, and
GBP7 (Fig. 4A). We next asked whether IL-1 secretion in re-
sponse to C. muridarum infections became GBP dependent once
BMMs were primed with LPS. In agreement with our hypothesis,
we found that LPS but not IFN- priming licensed GBP-depen-
dent IL-1 secretion (Fig. 4B). The secretion of constitutively ex-
pressed IL-18, on the other hand, remained GBP dependent re-
gardless of the priming agent (Fig. 4C). In further support for a
role for GBPs in regulating inflammasome activation, specifi-
cally at early times postinfection, we observed that the quantity
of IL-18 or IL-1 secreted in the 8- to 24-hpi time window was
similar between wild-type and GBPchr3/ BMMs (Fig. 4D and
E). These results suggested that only early (between 0 and 8
hpi) but not late (between 8 and 24 hpi) IL-18 and IL-1 pro-
cessing required GBPs. Collectively, these observations sup-
ported a model according to which GBPs promote inflam-
masome activation in response to C. muridarum infections with
fast kinetics but are not involved in inflammasome activation at
later times postinfection.
Canonical and noncanonical inflammasomes contribute to
Chlamydia-induced pyroptosis. To move toward an understand-
ing of the molecular role that GBPs play in controlling cellular
responses to Chlamydia infections, we set out to identify the spe-
cific types of inflammasomes activated by Chlamydia. Previously
only the canonical NLRP3 inflammasome was reported to be ac-
tivated by Chlamydia infections (11, 17, 18, 49). Here, we found
that C. muridarum induced robust cell death in IFN--primed
wild-type and Casp1/ BMMs at 8 hpi. Dually deficient
Casp1/ Casp11/ BMMs, on the other hand, were resistant to
C. muridarum-induced cell death, whereas Casp11/ BMMs
were moderately protected against cell death (Fig. 5A), demon-
strating that C. muridarum induces pyroptosis through both ca-
nonical and noncanonical inflammasomes. Similarly, pyroptosis
induced by C. trachomatis infections also was dependent on both
caspase-1 and caspase-11 (see Fig. S3 in the supplemental mate-
rial). Collectively, these data showed that Chlamydia infections in
FIG 3 GBPs promote IL-18 but not IL-1 secretion in IFN--primed BMMs infected with C. muridarum. Wild-type, GBPchr3/, and Casp1/ Casp11/
BMMs were primed with 100 U/ml IFN- or left unprimed. Subsequently, cells were infected with C. muridarum at an MOI of 30. IL-18 (A) and IL-1 (B)
concentrations of cell supernatants were determined by ELISA at 24 hpi. Data are displayed as means  SD from 4 independent wells and are representative of
3 experiments. (C and D) Wild-type and GBPchr3/ BMMs were primed with 100 U/ml IFN- or left untreated. Cells next were either infected with C.
muridarum at an MOI of 3 or left uninfected. RNA was extracted at 8 hpi, and relative IL-18 (C) and IL-1 (D) transcript levels were determined via qPCR. Data
are shown as means  SEM from 3 independent experiments. Two-way ANOVA was used to calculate statistical significance. *, P  0.05; ***, P  0.001; N.S.,
not significant.
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BMMs activated both canonical and noncanonical inflam-
masomes at 8 hpi. Because the induction of pyroptosis at 8 hpi in
Chlamydia-infected BMMs was GBP dependent (Fig. 2), these re-
sults strongly argued that GBPs regulated both canonical and non-
canonical inflammasome activation in response to Chlamydia in-
fections.
AIM2 and NLRP3 are required for IL-1 and IL-18 secretion
in Chlamydia-infected macrophages. While both caspase-1 and
caspase-11 were required for the execution of pyroptosis, we
found that only caspase-1 expression was essential for the secre-
tion of IL-1 and IL-18 following C. muridarum infections (Fig.
5B and C). These results demonstrated that C. muridarum infec-
FIG 4 GBPs promote fast-kinetics inflammasome activation. Wild-type BMMs were left unprimed or were primed with either 100 U/ml IFN- or 100 ng/ml
LPS. (A) Following priming for 6 h, RNA was extracted and GBP2, GBP3, GBP5, GBP7, and IL-1 mRNA expression was assessed by qPCR. Data are shown as
means  SEM from 3 independent experiments. (B to E) Wild-type, GBPchr3/, and Casp1/ Casp11/ BMMs were primed with 100 U/ml IFN- or 100
ng/ml LPS for 6 h and then infected with C. muridarum at an MOI of 30. Cell supernatants were collected at 8 and 24 hpi, and IL-1 (B) and IL-18 (D)
concentrations were determined by ELISA. Data are given as means  SD from 3 independent wells and represent one of three repeat experiments. Changes in
IL-1 (C) and IL-18 (E) cytokine levels between 8 and 24 hpi were determined by subtracting mean supernatant cytokine levels at 8 hpi from 24-hpi data. Data
are shown as means  SD from 3 independent wells. N.S., not significant; ***, P  0.001 (based on two-way ANOVA).
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tions induced IL-1 and IL-18 secretion independently of
caspase-11 activation. To identify the Chlamydia-induced canon-
ical inflammasome activation pathway, we set out to define the
repertoire of caspase-1-dependent canonical inflammasomes re-
sponsible for Chlamydia-induced IL-1 and IL-18 processing and
secretion. In accordance with previous reports (11, 17, 18, 49), we
found that Chlamydia-infected Nlrp3/ BMMs secreted less
IL-1 and IL-18 than wild-type BMMs did (Fig. 6; also see Fig. S4
and S5 in the supplemental material). However, IFN--primed
Nlrp3/ BMMs infected with C. muridarum secreted signifi-
cantly more IL-18 than caspase-1-deficient BMMs did at 24 hpi
(see Fig. S4), indicating that C. muridarum infections activate at
least one NLRP3-independent canonical inflammasome. To iden-
tify the additional C. muridarum-induced canonical inflam-
masome, we monitored IL-18 secretion in IFN--primed and C.
muridarum-infected Nlrp1/, Nlrp3/, Nlrc4/, Aim2/,
Asc/, and Casp1/ Casp11/ BMMs (see Fig. S4). We ob-
served a complete defect in IL-18 secretion in Asc/ and
Casp1/ Casp11/ BMMs, a partial reduction in IL-18 secre-
tion in Nlrp3/ and Aim2/ BMMs, and no change in IL-18
secretion in Nlrp1/ and Nlrc4/ BMMs relative to that of wild-
type BMMs (see Fig. S4), implying a role for AIM2 in the cellular
response to C. muridarum infections. In further support of C.
muridarum-triggered AIM2 activation, we found that dually defi-
cient Nlrp3/ Aim2/ BMMs primed with IFN- or LPS failed
to secrete IL-1 or IL-18 in response to C. muridarum infections,
whereas Nlrp3/ BMMs displayed a partial defect at 24 hpi (Fig.
6A and B). Infections with C. trachomatis also induced both
AIM2- and NLRP3-dependent cellular responses at 24 hpi (see
Fig. S5), demonstrating that AIM2- and NLRP3-containing in-
flammasomes mediate IL-1 and IL-18 secretion in response to
Chlamydia infections.
Fast induction of IL-18 secretion in IFN--primed macro-
phages requires NLRP3 but not AIM2. Lastly, we asked whether
fast-kinetics inflammasome activation in response to C. muri-
darum infections was dependent on NLRP3 or AIM2 by monitor-
ing cytokine secretion at 8 hpi. We observed that IL-18 secretion at
8 hpi in IFN--primed BMMs was dependent solely on NLRP3
(Fig. 6B). Because IL-18 secretion is partially dependent on GBPs
under these experimental conditions (Fig. 4C), these data indi-
cated that GBPs specifically promoted the activation of the NLRP3
inflammasome, as previously reported (50). Unexpectedly, we no-
ticed a moderate but reproducible increase in IL-18 and IL-1
secretion in IFN--primed Aim2/ BMMs that we failed to ob-
serve under LPS priming conditions (Fig. 6A and B). Instead,
AIM2 played a more prominent role in IL-18 and IL-1 secretion
in LPS-primed BMMs, suggesting that LPS and IFN- differen-
tially modulate AIM2 and NLRP3 activities by an unknown mech-
anism. Regardless of the priming stimulus, we found that AIM2
and NLRP3 both contributed to IL-18 and IL-1 secretion at 24
hpi (Fig. 6A and B). While a role for GBPs in Chlamydia-induced
AIM2 activation could not be excluded at this time, our observa-
tions strongly suggested that GBPs controlled the rapid activation
of the NLRP3 inflammasomes in C. muridarum-infected BMMs.
DISCUSSION
IFN--inducible GBPs provide cell-autonomous resistance to vi-
ral, bacterial, and protozoan pathogens (19, 23, 24, 41, 51–53).
More recently, GBPs were implicated as cellular cofactors re-
quired for canonical and noncanonical inflammasome activation
in response to bacterial infections (20, 22, 50, 54–56). While all of
these recent studies showed that GBPs augmented cellular re-
sponses associated with inflammasome activation, they differed
substantially in the proposed modes of action by which GBPs
regulate inflammasomes (20, 50, 54, 55). One matter of conten-
tion revolves around the question of whether or not GBPs need to
bind to and lyse PVs in order to activate inflammasomes (20, 22,
FIG 5 C. muridarum infections activate canonical and noncanonical inflam-
masomes. Wild-type, Casp1/, Casp11/, and Casp1/ Casp11/ BMMs
were primed with 100 U/ml IFN- or left unprimed and subsequently infected
with C. muridarum at an MOI of 30. (A) LDH release was measured at 8 hpi.
IL-1 (B) and IL-18 (C) cytokine concentrations in cell supernatants were
measured via ELISA at 24 hpi. Data are shown as means  SD from 3 inde-
pendent wells. Data are representative of 3 independent experiments. N.S., not
significant; ***, P  0.001 (based on two-way ANOVA).
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50). Here, we identified C. muridarum as a pathogen that evades
GBP binding to its surrounding vacuole yet still activates inflam-
masomes in a partially GBP-dependent manner. While we do not
necessarily dismiss a role for GBPs in PV lysis, our observations
argue that GBPs play an important role in inflammasome activa-
tion by a vacuolar pathogen that is independent of PV lysis.
At least three models have been put forward to account for the
role of GBPs in inflammasome activation. For vacuolar pathogens
it was proposed that GBPs mediate PV lysis, thereby allowing for
the spillage of PAMPs into the host cytosol (20). In support of this
model, GBPs were previously shown to promote the destruction
of parasitophorous vacuoles formed by Toxoplasma gondii (24).
However, our current observations in a C. muridarum infection
model and our previous studies on L. pneumophila (22) failed to
identify a link between GBPs and PV lysis. These observations
made in distinct infection models are not necessarily contradic-
tory to one another and could be explained if both GBP-depen-
dent and GBP-independent PV lysis pathways existed that are of
varying importance depending on the pathogen or experimental
conditions used. Circumstantial evidence supports the existence
of GBP-independent PV lysis pathways: we previously found that
Galectin-3, a marker of disrupted vacuoles, colocalizes with Legio-
nella-containing vacuoles in GBPchr3/ BMMs (22); here, we ob-
served that C. muridarum establishes productive inclusions in
only a fraction of infected BMMs regardless of the GBP genotype
(Fig. 1 and data not shown), while dispersed chlamydial LPS is
found in the majority of both wild-type and GBPchr3/ BMMs
(data not shown). Whether or not the GBP-independent loss of
vacuolar integrity observed for Legionella-containing vacuoles
and Chlamydia inclusions is the result of host-directed PV lysis
will require further investigation.
In addition to PV lysis, GBPs also have been characterized as
mediators of direct bacteriolysis. Recent studies demonstrated
that GBPs were required for inflammasome activation in response
to infections with Francisella novicida, a pathogen that actively
egresses from its phagosome into the host cytosol (54, 55). As it
was shown that GBPs bind to cytosolic F. novicida, it seems plau-
sible that GBPs also could bind to and lyse PV-resident pathogens,
such as L. pneumophila or Chlamydia, once these pathogens have
been expelled from their respective vacuolar niches. While this
hypothesis is attractive and deserves further testing, we have failed
to observe any association of cytosolically expelled Chlamydia and
GBP proteins (data not shown). GBP-dependent bacteriolysis also
would be expected to release bacterial DNA, thereby triggering
robust AIM2 activation. However, the data presented here and in
previous studies suggest that GBPs promote predominantly
caspase-11 and NLRP3 inflammasome activation in response to
infections with the vacuolar pathogens C. muridarum, S. Typhi-
murium, and L. pneumophila (20, 22, 50). Therefore, we favor a
model in which GBPs directly promote caspase-11 and NLRP3
inflammasome activation. Our model is in agreement with a pre-
vious report demonstrating that at least one member of the GBP
family, i.e., GBP5, can complex with the inflammasome sensor
FIG 6 Differential activation of AIM2 and NLRP3 inflammasomes by C. muridarum in IFN-- and LPS-primed macrophages. Wild-type, Aim2/, Nlrp3/,
and Aim2/ Nlrp3/ BMMs were primed with 100 U/ml IFN- or 100 ng/ml LPS. Cells were infected with C. muridarum and supernatants collected at 8 or
24 hpi. Concentrations of IL-1 (A) and IL-18 (B) in cell supernatants were measured by ELISA. Data are depicted as means  SD from 3 independent wells and
are representative of 2 experiments. Statistical significance was calculated using two-way ANOVA. *, P  0.05; **, P  0.01; ***, P  0.001; N.S., not significant.
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protein NLRP3 and can alter its activity (50), although this asser-
tion has been challenged (20, 54).
As already alluded to, a third mechanism of action by which
GBPs control inflammasome responses was proposed, according
to which at least one GBP family member promotes NLRP3-ASC
oligomerization. It was shown that tetrameric GBP5 promotes
NLRP3-dependent ASC oligomerization, potentially through the
clustering of PYD domains (50). These observations raised several
important questions, one of which pertained to the nature of the
stimulus that would induce GBP5 tetramerization. We propose
that infectious agents, which include Chlamydia species, release
unidentified PAMPs or DAMPs that trigger tetramerization of
GBP5 and potentially tetramerization of other GBPs controlling
inflammasome function. A second question prompted by these
previous studies concerns whether additional GBPs other than
GBP5 physically and functionally interact with inflammasome
components. While our studies were conducted in BMMs lacking
5 GBP-encoding genes, including GBP5, future studies will ad-
dress which specific GBPs augment inflammasome activation in
response to Chlamydia infections.
Here, we also made the unexpected observation that GBPs
were specifically required for fast-kinetics inflammasome activa-
tion that occurred within the first 8 h after C. muridarum infec-
tion. We observed that rapid GBP-dependent inflammasome ac-
tivation was specifically induced by viable, metabolically active C.
muridarum (data not shown), alluding to the possibility that an
event occurring during the initial stage of the Chlamydia infec-
tious cycle triggers GBP-dependent responses. Alternatively, the
relatively low abundance of inflammasome stimuli during the ini-
tial phase of the infection may require GBPs as high-affinity am-
plifiers, a requirement that expires at later stages of the infection.
The discovery of GBP-interacting molecules most likely will shed
more light on the mechanism by which GBPs accelerates inflam-
masome activation and reveal why GBPs are uniquely required for
fast-kinetics inflammasome activation in C. muridarum-infected
cells.
Interestingly, we observed that changes in the kinetics of ca-
nonical inflammasome activation could alter the quality of the
macrophage response to C. muridarum infections: because IFN-
induces the expression of GBPs but not IL-1, GBP-driven rapid
inflammasome activation in IFN--primed macrophages results
in the preferential processing of constitutively expressed IL-18.
The immunological activities of IL-1 and IL-18 are distinct and
sometimes antagonistic (48, 57). Therefore, GBP-dependent al-
terations in the relative secretion of IL-1 versus IL-18 could im-
pact the immune response to Chlamydia and other pathogens that
trigger GBP-dependent inflammasome pathways during a Th1-
biased immune response. Therefore, our future studies will ad-
dress whether GBPs control inflammation-associated pathologies
in the context of infections with Chlamydia and other pathogens
and whether therapeutic intervention targeting GBPs can alter the
course and outcome of inflammation.
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